Predict your next investment

HEALTHCARE | Pharmaceuticals / Drugs

See what CB Insights has to offer

Founded Year

1993

Stage

Acq - P2P | Acquired

Total Raised

$131.86M

About Guilford Pharmaceuticals

Guilford Pharmaceuticals is a pharmaceutical company engaged in the research, development and commercialization of products that target the hospital market. Guilford's marketed products include the Gliadel Wafer for brain tumor treatment, and their product pipeline includes a novel anesthetic, Aquavan Injection.

Guilford Pharmaceuticals Headquarter Location

6611 Tributary Street Suite 100

Baltimore, Maryland, 21224,

United States

410-631-6300

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Guilford Pharmaceuticals

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Guilford Pharmaceuticals is included in 4 Expert Collections, including Pharma Startups.

P

Pharma Startups

6,549 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

C

Cancer Therapeutics

1,179 items

Pharmaceutical and biotechnology companies with cancer therapy drug candidates.

N

Neuroscience

2,144 items

Companies developing products that monitor, analyze, protect, or otherwise influence the structure/function of the nervous system.

C

Cancer

4,844 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

Guilford Pharmaceuticals Patents

Guilford Pharmaceuticals has filed 1 patent.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

2/25/2003

1/20/2009

Polymers, Drug delivery devices, Nanomaterials, Dosage forms, Membrane biology

Grant

Application Date

2/25/2003

Grant Date

1/20/2009

Title

Related Topics

Polymers, Drug delivery devices, Nanomaterials, Dosage forms, Membrane biology

Status

Grant

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.